REFERENCES
N. Rahman and M. R. Stratton (1998). The genetics of breast cancer susceptibility. Annu. Rev. Genet. 32:95-121.
K. N. Nathanson, R. Wooster, and B. L. Weber (2001). Breast cancer genetics: What we know and what we need. Nat. Med. 7(5):552-556.
R. Scully and D. M. Livingston (2000). In search of the tumour-suppressor functions of BRCA1 and BRCA2. Nature 408(6811):429-432.
A. R. Venkitaraman (2002). Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 108(2):171-182.
H. Meijers-Heijboer, A. van den Ouweland, J. Klijn, M. Wasielewski, A. de Snoo, R. Oldenburg, A. Hollestelle, M. Houben, E. Cropin, M. van Veghel-Plandsoen, F. Elstrodt, C. van Duijn, C. Bartels, C. Meijers, M. Schulte, L. McGuffog, D. Thompson, D. Easton, N. Sodha, S. Seal, R. Barfoot, J. Mangion, D. Eccles, R. Eeles, D. G. Evans, R. Houlston, V. Murday, S. Narod, T. Peretz, J. Peto, C. Phelan, H. X. Zhang, C. Szabo, P. Devilee, D. Goldgar, P. A. Futreal, K. L. Nathanson, B. Weber, N. Rahman, and M. R. Stratton, (2002). Low-penetrance susceptibility to breast cancer due to CHEK2(*) 1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat. Genet. 31(1):55-59.
D. W. Bell, J. M. Varley, T. E. Szydlo, D. H. Kang, D. C. Wahrer, K. E. Shannon, N. Lubratovich, S. J. Verselis, K. J. Isselbacher, J. F. Fraumeni, J. M. Birch, F. P. Li, J. E. Garther, and D. A. Haber. (1999). Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. Science 286(5449):2528- 2531.
D. F. Easton (1999). How many more breast cancer predispo-sition genes are there? Breast Cancer Res. 1(1):14-17.
E. C. Friedberg, G. C. Walker, and W. Siede (1995). DNA Re-pair and Mutagenesis. ASM Press, Washington, D.C.
M. M. Cox, M. F. Goodman, K. N. Kreuzer, D. J. Sherratt, S. J. Sandler, and K. J. Marians (2000). The importance of repairing stalled replication forks. Nature 404(6773):37-41.
T. R. Cech (2004). Beginning to understand the end of the chromosome. Cell 116(2):273-279.
S. Shreeram and J. J. Blow. The role of the replication licens-ing system in cell proliferation and cancer. Prog. Cell Cycle Res. 5:287-293.
J. Pines and C. L. Rieder (2001). Restaging mitosis: A contem-porary view of mitotic progression. Nat. Cell Biol. 3(1):E3-E6.
E. A. Nigg (2002). Centrosome aberrations: Cause or conse-quence of cancer progression? Nat. Rev. Cancer2(11):815- 825.
A. L. Jackson and L. A. Loeb (1998). On the origin of multiple mutations in human cancers. Semin Cancer Biol. 8(6):421-429.
L. A. Loeb, K. R. Loeb, and J. P. Anderson (2003). Multiple mutations and cancer. Proc. Natl. Acad. Sci. U.S.A. 100(3):776-781.
B. A. J. Ponder and W. K. Cavanee (1995). Genetics and Cancer: A Second Look. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
J. Brugarolas and T. Jacks (1997). Double indemnity: p53, BRCA and cancer. p53 mutation partially rescues develop-mental arrest in Brca1 and Brca2 null mice, suggesting a role for familial breast cancer genes in DNA damage repair [news]. Nat. Med. 3(7):721-722.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Venkitaraman, A.R. Preface: Chromosomal Instability and Breast Cancer Pathogenesis. J Mammary Gland Biol Neoplasia 9, 217–220 (2004). https://doi.org/10.1023/B:JOMG.0000048769.24125.64
Issue Date:
DOI: https://doi.org/10.1023/B:JOMG.0000048769.24125.64